-
Abstract Number: 869
Clinical Manifestations of Patients with Eosinophilic Granulomatosis with Polyangiitis in a Large North American Cohort
-
Abstract Number: 870
Off-Label Use of Biotherapies to Treat Relapsing And/or Refractory Eosinophilic Granulomatosis with Polyangiitis (Churg–Strauss)
-
Abstract Number: 871
ANCA-Associated Vasculitis Management in the United States: Data from the RISE Registry
-
Abstract Number: 872
Granulomatosis with Polyangiitis Sustained Remission Off-Therapy: Data from the French Vasculitis Study Group Registry
-
Abstract Number: 873
Survival After Lung Transplantation in Adults with Primary Systemic Vasculitides: Analysis of the United Network of Organ Sharing (UNOS) Database
-
Abstract Number: 874
Comparative Analysis Between ANCA-associated Interstitial Lung Disease and Interstitial Pneumonitis with Autoimmune Features
-
Abstract Number: 875
Effect of the Dr. Bart Application on Healthcare Use and Clinical Outcomes in People with Osteoarthritis of the Knee And/or Hip in the Netherlands; A Randomized Controlled Trial
-
Abstract Number: 876
“When You Read This, You Really Feel Old!” Perspectives of Young People with Inflammatory Arthritis on Patient Reported Outcome Measures from a European Qualitative Study
-
Abstract Number: 877
Rheumatoid Arthritis Patients’ Perspectives on Tapering of Biologics: A Qualitative Study
-
Abstract Number: 878
The Association of Serum Magnesium with Chondrocalcinosis and Osteoarthritis
-
Abstract Number: 879
Evaluation of Marijuana and Cannabidiol Use in the Rheumatologic Population from a Patient and Clinician Perspective: A Survey-Based Study
-
Abstract Number: 880
Diseased Lupus Nephritis Kidneys Serve as a Primary Site of Systemic Autoimmune Development
-
Abstract Number: 881
Auto-antibodies Targeting Components of Sarcolemma Repair: A Pathogenic Mechanism in Human Inflammatory Myopathies
-
Abstract Number: 882
Serum Anti-Vimentin Autoantibodies May Uniquely Predict Response to Therapy in Lupus Nephritis
-
Abstract Number: 883
B Cell-specific MyD88 Regulates Pathology After Disease Onset in Murine Lupus
- « Previous Page
- 1
- …
- 59
- 60
- 61
- 62
- 63
- …
- 198
- Next Page »